Living well with Chronic lymphocytic leukaemia

Published 2026-01-12 · cll, blood cancer · MyCBC Blog

Living well with Chronic lymphocytic leukaemia, CLL, blood cancer: life expectancy, prognosis and practical steps

Photo by National Cancer Institute on Unsplash

Chronic lymphocytic leukaemia, CLL, blood cancer is one of the most common types of adult leukaemia. Many people diagnosed with this condition live for years or decades, often with periods that require no active treatment. This guide explains what influences life expectancy, when treatment is needed, and practical steps you can take to protect your health and quality of life.

What is Chronic lymphocytic leukaemia, CLL, blood cancer?

Chronic lymphocytic leukaemia is a slow-growing cancer of the white blood cells. It typically affects older adults and often progresses more slowly than other blood cancers. In many cases CLL is found during routine blood tests before symptoms appear. Because its course varies widely, management ranges from regular monitoring without treatment to targeted therapies when disease progresses.

How long can someone live with CLL?

Prognosis for CLL has improved substantially over recent years. Many people live for many years after diagnosis; some remain stable for decades without needing treatment. Modern therapies also allow people who need treatment to achieve long remissions and live close to normal life expectancy for their age.

Important context about statistics:

• Survival rates (for example five year survival percentages) describe groups of people and do not predict a single person’s outcome.
• Median age at diagnosis is around 70, so other age-related health issues also affect overall survival statistics.
• Individual life expectancy depends on disease biology, age, other health conditions and how quickly the CLL progresses.

Key factors that influence prognosis

Several measurable and clinical factors help doctors estimate how CLL might behave:

• Genetics and biology of the CLL cells: Tests that check for markers such as TP53 mutations, 17p deletion and IGHV status give strong clues about likely disease behaviour and response to certain treatments.
• Blood counts and lymphocyte trend: How fast the lymphocyte count rises and whether haemoglobin or platelets fall are important signals.
• Symptoms and organ involvement: Significant fatigue, weight loss, frequent infections, enlarged lymph nodes or spleen, and low blood counts may indicate the need for therapy.
• Age and other medical conditions: Heart disease, diabetes and other comorbidities affect both treatment options and overall outcomes.

When is treatment recommended versus "watch and wait"?

Not everyone with Chronic lymphocytic leukaemia, CLL, blood cancer needs immediate treatment. Many people are managed with active surveillance or "watch and wait" until specific criteria are met. Treatment is usually recommended if you have:

• Progressive drop in blood counts causing anaemia or low platelets
• Bulky or growing lymph nodes or spleen causing symptoms
• Significant or worsening symptoms such as fatigue, night sweats, fever or weight loss
• Rapid lymphocyte doubling time or other signs of aggressive disease

When treatment is needed, newer targeted drugs have transformed outcomes. Options include kinase inhibitors and BCL2-targeting therapy, often combined with antibody therapy. Choice of treatment depends on molecular test results, overall health and prior therapies.

Practical steps to live longer and feel better with CLL

Beyond medical care, everyday choices can support longevity and quality of life. The following actions are practical and evidence informed:

• Keep scheduled monitoring with blood tests and clinic visits. Early detection of change means earlier, more effective treatment when required.
• Stay up to date with vaccinations (discuss timing with your specialist; avoid live vaccines if you are significantly immunosuppressed).
• Prioritise sleep and stress management because immune function and recovery improve with good rest and lower chronic stress.
• Exercise regularly — aim for around 30 minutes of daily activity when possible. Even light resistance training can help strength, immunity and capacity to tolerate treatment.
• Maintain a balanced diet focused on whole foods, and address vitamin or mineral deficiencies with your doctor.
• Reduce infection risk — practice good hand hygiene, avoid close contact with sick people, and plan dental and surgical procedures with your care team.
• Consider specialist centres and clinical trials as they often provide access to the latest therapies.

Monitoring frequency — general guidance

Monitoring schedules vary by individual. For many people with stable CLL, clinic visits and blood tests every 3 to 12 months are common. If counts or symptoms change, monitoring becomes more frequent. Your haematologist will recommend a personalised plan.

Common misconceptions and what to watch out for

• Misconception: CLL is always rapidly fatal. Reality: Many people live long, well years with no or minimal treatment.
• Misconception: A rising white blood cell count always means immediate danger. Reality: Counts can fluctuate with infection or other stresses; trends and symptoms matter more than a single result.
• Watch out: Delay in reporting symptoms like new fatigue, fevers, recurrent infections or bleeding. Early reporting helps the team act promptly.

Questions to ask your doctor

• What do my genetic and molecular test results mean for my prognosis and treatment options?
• How often should I have blood tests and clinic visits right now?
• At what point would you recommend starting treatment?
• What side effects should I expect from likely treatment choices?
• Are there lifestyle changes or vaccinations I should prioritise?
• Should I consider a clinical trial or referral to a specialist centre?

Takeaway

Chronic lymphocytic leukaemia, CLL, blood cancer is usually a chronic condition rather than an immediate life-limiting disease. Many people live for many years and maintain a high quality of life. Regular monitoring, understanding your disease biology, staying current with vaccinations and healthy living all contribute to better outcomes. Work closely with your haematology team to build a plan that fits your situation and gives you the best chance of a long, active life.